Effect of Oxaliplatin on Voltage-Gated Sodium Channels in Peripheral Neuropathic Pain

被引:7
|
作者
Kim, Woojin [1 ]
机构
[1] Kyung Hee Univ, Dept Physiol, Coll Korean Med, Seoul 02453, South Korea
关键词
allodynia; oxaliplatin; peripheral neuropathic pain; voltage-gated sodium channel; INDUCED NEUROTOXICITY; ANTICANCER AGENT; PREVENTION; NA+; EXPRESSION; DULOXETINE; POTENTIALS; MECHANISMS; MANAGEMENT; JUNCTIONS;
D O I
10.3390/pr8060680
中图分类号
TQ [化学工业];
学科分类号
0817 ;
摘要
Oxaliplatin is a chemotherapeutic drug widely used to treat various types of tumors. However, it can induce a serious peripheral neuropathy characterized by cold and mechanical allodynia that can even disrupt the treatment schedule. Since the approval of the agent, many laboratories, including ours, have focused their research on finding a drug or method to decrease this side effect. However, to date no drug that can effectively reduce the pain without causing any adverse events has been developed, and the mechanism of the action of oxaliplatin is not clearly understood. On the dorsal root ganglia (DRG) sensory neurons, oxaliplatin is reported to modify their functions, such as the propagation of the action potential and induction of neuropathic pain. Voltage-gated sodium channels in the DRG neurons are important, as they play a major role in the excitability of the cell by initiating the action potential. Thus, in this small review, eight studies that investigated the effect of oxaliplatin on sodium channels of peripheral neurons have been included. Its effects on the duration of the action potential, peak of the sodium current, voltage-response relationship, inactivation current, and sensitivity to tetrodotoxin (TTX) are discussed.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Voltage-gated sodium channels and neuropathic pain
    Chung, Kyungsoon
    Chung, Jin Mo
    NOCICEPTIVE MEMBRANE, 2006, 57 : 311 - 321
  • [2] Modulators of peripheral voltage-gated sodium channels for the treatment of neuropathic pain
    Gribkoff, VK
    Winquist, RJ
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2005, 15 (12) : 1751 - 1762
  • [3] The role of voltage-gated sodium channels in neuropathic pain
    Lai, J
    Hunter, JC
    Porreca, F
    CURRENT OPINION IN NEUROBIOLOGY, 2003, 13 (03) : 291 - 297
  • [4] The role of voltage-gated sodium channels in neuropathic pain
    Maingret, F.
    Delmas, P.
    DOULEUR ET ANALGESIE, 2008, 21 (04): : 194 - 202
  • [5] Voltage-gated sodium channels as molecular targets for neuropathic pain
    Priestley, Tony
    Hunter, John C.
    DRUG DEVELOPMENT RESEARCH, 2006, 67 (04) : 360 - 375
  • [6] Targeting Voltage-Gated Sodium Channels for Treating Neuropathic and Inflammatory Pain
    Cohen, Charles J.
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2011, 12 (10) : 1715 - 1719
  • [7] Voltage-Gated Sodium Channels and Pain
    Priestley, T.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2004, 3 (06) : 441 - 456
  • [8] Peripheral Voltage-Gated Cation Channels in Neuropathic Pain and Their Potential as Therapeutic Targets
    Alles, Sascha R. A.
    Smith, Peter A.
    FRONTIERS IN PAIN RESEARCH, 2021, 2
  • [9] Voltage-gated Na+ channels in neuropathic pain
    Hargus, Nicholas-James
    Patel, Manoj Kumar
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (05) : 635 - 646
  • [10] Voltage-gated sodium channels and pain pathways
    Wood, JN
    Boorman, JP
    Okuse, K
    Baker, MD
    JOURNAL OF NEUROBIOLOGY, 2004, 61 (01): : 55 - 71